196 related articles for article (PubMed ID: 68118)
21. Serum pancreatic oncofetal antigen: its clinical usefulness for screening pancreatic cancer in combination with tests for other tumor markers.
Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
Gastroenterol Jpn; 1983 Oct; 18(5):487-91. PubMed ID: 6197338
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of oncofetal proteins and hormones as tumor markers.
Garrett PE; Kurtz SR
Med Clin North Am; 1986 Nov; 70(6):1295-306. PubMed ID: 2431237
[TBL] [Abstract][Full Text] [Related]
23. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
24. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Kuusela P; Haglund C; Roberts PJ; Jalanko H
Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
26. alpha-Fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin and its beta subunit in metastatic choriocarcinoma: short-term follow-up and determinations of resistance during chemotherapy.
Gips H; Vahrson H; Bailer P; Korte K
Oncology; 1980; 37(3):157-62. PubMed ID: 6153786
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical localization of neuroendocrine hormones and oncofetal antigens in ovarian teratomas.
Calame J; Bosman FT; Schaberg A; Louwerens JW
Int J Gynecol Pathol; 1984; 3(1):92-100. PubMed ID: 6203857
[TBL] [Abstract][Full Text] [Related]
29. Combined effusion fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (hCG), in the detection of malignant tumors.
Couch WD
Cancer; 1981 Dec; 48(11):2475-9. PubMed ID: 7296495
[TBL] [Abstract][Full Text] [Related]
30. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
32. [A case of yolk sac tumor originating in the thymus with elevated serum AFP, HCG and CEA (author's transl)].
Arimura T; Baba K; Tanaka T; Fukami A; Mitani N; Takao S; Kawaida T; Nishi M; Nakagama H; Sonoda T; Tanaka S
Nihon Kyobu Geka Gakkai Zasshi; 1981 Jul; 29(7):1233-42. PubMed ID: 6170709
[No Abstract] [Full Text] [Related]
33. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
34. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
Tanimura T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
[TBL] [Abstract][Full Text] [Related]
35. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
36. Choriocarcinoma: expression of tumor- and trophoblast-associated antigens in patients with low chorionic gonadotropin excretion.
Seppälä M; Rutanen EM; Ranta T; Aho I; Nieminen U; Unnérus HA; Saksela E
Cancer; 1976 Nov; 38(5):2065-70. PubMed ID: 62610
[TBL] [Abstract][Full Text] [Related]
37. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
38. Multiple biochemical markers in patients with gynecologic malignancies.
Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
[TBL] [Abstract][Full Text] [Related]
39. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
